Skip to content
10-Q

Quarterly Report

Orthofix Medical Inc. OFIX

0001193125-26-205003

← back to feed
Filed
May 5, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 1, 2026 40.42M sh
Shares Diluted Q1 2026 · Mar 31, 2026 40.45M sh
Shares Diluted Q1 2026 · Mar 31, 2025 39.19M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$17.61M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$18.39M
Long Term Debt Q1 2026 · Mar 31, 2026 $221.34M
Long Term Debt Q1 2026 · Dec 31, 2025 $157.39M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $120.28M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $82.03M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $57.95M
Stockholders Equity Q1 2026 · Mar 31, 2026 $435.19M
Stockholders Equity Q1 2026 · Dec 31, 2025 $450.04M
Stockholders Equity Q1 2026 · Mar 31, 2025 $458.29M
Stockholders Equity Q1 2026 · Dec 31, 2024 $503.12M
Current Liabilities Q1 2026 · Mar 31, 2026 $161.03M
Current Liabilities Q1 2026 · Dec 31, 2025 $170.48M
Total Liabilities Q1 2026 · Mar 31, 2026 $451.42M
Total Liabilities Q1 2026 · Dec 31, 2025 $400.61M
Current Assets Q1 2026 · Mar 31, 2026 $461.52M
Current Assets Q1 2026 · Dec 31, 2025 $416.85M
Total Assets Q1 2026 · Mar 31, 2026 $886.6M
Total Assets Q1 2026 · Dec 31, 2025 $850.65M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.52
Eps Diluted Q1 2026 · Mar 31, 2025 −$1.35
Eps Basic Q1 2026 · Mar 31, 2026 −$0.52
Eps Basic Q1 2026 · Mar 31, 2025 −$1.35
Sga Expense Q1 2026 · Mar 31, 2026 $134.91M
Sga Expense Q1 2026 · Mar 31, 2025 $132.98M
Rd Expense Q1 2026 · Mar 31, 2026 $15.32M
Rd Expense Q1 2026 · Mar 31, 2025 $19.77M
Net Income Q1 2026 · Mar 31, 2026 −$20.91M
Net Income Q1 2026 · Mar 31, 2025 −$53.09M
Operating Income Q1 2026 · Mar 31, 2026 −$14.44M
Operating Income Q1 2026 · Mar 31, 2025 −$48.87M
Gross Profit Q1 2026 · Mar 31, 2026 $139.55M
Gross Profit Q1 2026 · Mar 31, 2025 $121.62M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $57.16M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $72.03M
Revenue Q1 2026 · Mar 31, 2026 $196.71M
Revenue Q1 2026 · Mar 31, 2025 $193.65M